Serial dilution transplantation assays verified similar leukemogenic capacity of untreated Gata1-deficient and control clones (Supplementary Fig. 7a; and see below), and all resulting leukemias were immunophenotypically immature (Supplementary Fig. 7b). This evidence concerns the gene GATA1 and leukemia.